Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-adrenergic receptors in the nasal mucosa are G protein-coupled receptors located primarily on the smooth muscle of precapillary and postcapillary blood vessels. Activation of these receptors causes vasoconstriction, reducing blood flow and congestion. The main subtypes are alpha1-adrenoceptors and alpha2-adrenoceptors. Drugs like phenylephrine and oxymetazoline act as agonists to relieve nasal congestion. Excessive use can lead to rebound congestion.
Agonist at alpha-adrenergic receptors leading to vasoconstriction in the nasal mucosa, reducing blood flow and congestion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-Adrenergic Receptor (Nasal Mucosa).